Magnacent 150I.U Injection
Alkem Laboratories Ltd

prescription required

Bookmark
In-stock 1 Injection in 1 vial
1,669.00

NOTICE: unsafe with : Pregnancy

USED FOR:
Female infertility Male hypogonadism Male infertility

COMPOSITION:
Menotrophin (150i.u)

Therapeutic Uses:
gynaecological

Related Warnings
Alcohol

Interaction with alcohol is unknown. Please consult your doctor.

CAUTION
Pregnancy
CAUTION

Magnacent 150I.U Injection is highly unsafe to use during pregnancy.Human and animal studies have shown significant adverse effects on the foetus. Please consult your doctor.

Lactation

No information is available on the use of Magnacent 150I.U Injection during lactation. Please consult your doctor.

Driving

It is not known whether Magnacent 150I.U Injection alters the ability to drive. Do not drive if you experience any symptoms that affect your ability to concentrate and react.

Kidney

There is limited information available on the use of Magnacent 150I.U Injection in patients with kidney disease. Please consult your doctor.

Liver

There is limited information available on the use of Magnacent 150I.U Injection in patients with liver disease. Please consult your doctor.

Menotrophin   150i.u

Uses of Magnacent Injection
Magnacent 150I.U Injection is used in the treatment of female infertility, male hypogonadism and male infertility.

How to use Magnacent Injection
Your doctor or nurse will give you this medicine. Kindly do not self administer.

How Magnacent Injection works
In females, Magnacent 150I.U Injection increases the number of growing eggs and stimulates their development. In males, it helps in the maturation of cells which produce male hormone like testosterone.

Side Effects:

Common Headache, Injection site allergic reaction, Injection site pain, Abdominal swelling, Abdominal pain, OHSS (Ovarian hyperstimulation syndrome), Abdominal cramp.

Expert advice for Magnacent Injection


If you are having periods, your treatment will start within the first 7 days of your menstrual cycle and will continue for up to 3 weeks.
You will be monitored for ovarian activity by measuring urinary estrogen at regular intervals, until stimulation occurs.
Take special care if you had infertility treatment in the past.
Refrain from sexual intercourse or use barrier contraception methods for at least 4 days and pelvic examinations to be avoided or carried out with care.